METTL14 and breast carcinoma: PAK5 kinase acts on its targets mainly through phosphorylation and we overexpressed PAK5 in breast cancer cells and identified METTL14 with a phosphorylation site at serine 399 using phosphorylation mass spectrometry (Fig. S4A).